Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction

NCT00006062 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Liver Disease

Interventions

DRUG: oxaliplatin

Sponsor

National Cancer Institute (NCI)